| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1111/J.1365-2133.2008.08876.X |
| P698 | PubMed publication ID | 18945303 |
| P50 | author | Carle Paul | Q55602005 |
| P2093 | author name string | S Prey | |
| P2860 | cites work | Identifying relevant studies for systematic reviews | Q36888457 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| methotrexate | Q422232 | ||
| systematic review | Q1504425 | ||
| P304 | page(s) | 622-628 | |
| P577 | publication date | 2008-10-20 | |
| P1433 | published in | British Journal of Dermatology | Q4970191 |
| P1476 | title | Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review | |
| P478 | volume | 160 |
| Q53545142 | A sandwich substrate for ultrasensitive and label-free SERS spectroscopic detection of folic acid / methotrexate. |
| Q33983913 | A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis |
| Q37099103 | Adverse drug reactions caused by methotrexate in Saudi population |
| Q53247484 | Beneficial effects of Chrysin against Methotrexate-induced hepatotoxicity via attenuation of oxidative stress and apoptosis. |
| Q26852235 | Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis |
| Q40590985 | British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016. |
| Q88300304 | Clinical connection between rheumatoid arthritis and liver damage |
| Q64898735 | Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology. |
| Q34140474 | Efficacy and safety of methotrexate in alopecia areata |
| Q43007068 | Elevated level of serum cystatin-C concentration is a useful predictor for myelosuppression induced by methotrexate for treatment of rheumatoid arthritis |
| Q42110834 | Fat Necrosis of the Breast Following Folinic Acid Extravasation |
| Q38223934 | Folate supplementation reduces the side effects of methotrexate therapy for psoriasis. |
| Q33654733 | Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease |
| Q26773684 | Hepatic manifestations of non-steroidal inflammatory bowel disease therapy |
| Q55114620 | Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review. |
| Q39243858 | Juvenile idiopathic arthritis: management and therapeutic options |
| Q37610517 | Lack of association between elevated mean red cell volume and haematological toxicity in patients receiving long-term methotrexate for rheumatoid arthritis |
| Q35973265 | Low-dose methotrexate inhibits methionine S-adenosyltransferase in vitro and in vivo |
| Q38194199 | Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies |
| Q55617607 | Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting. |
| Q41610932 | Methotrexate in pediatric plaque-type psoriasis: Long-term daily clinical practice results from the Child-CAPTURE registry |
| Q43259353 | Methotrexate in rheumatology |
| Q38115004 | Potential food-drug interactions in patients with rheumatoid arthritis |
| Q34418506 | Psoriasis and comorbidities: links and risks |
| Q37358239 | Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis |
| Q39128261 | Relative risk of and determinants for adverse events of methotrexate prescribed at a low dose: a systematic review and meta-analysis of randomized placebo-controlled trials |
| Q38687132 | Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity |
| Q38380882 | Systemic methotrexate for the treatment of psoriasis. |
| Q34356265 | Systemic methotrexate therapy for psoriasis: past, present and future. |
| Q38098061 | The effect of folate supplementation on methotrexate efficacy and toxicity in psoriasis patients and folic acid use by dermatologists in the USA. |
| Q36027291 | Therapeutic potential of folic acid supplementation for cardiovascular disease prevention through homocysteine lowering and blockade in rheumatoid arthritis patients. |
| Q38267703 | Three decades of low-dose methotrexate in rheumatoid arthritis: can we predict toxicity? |
| Q34047653 | Use of methotrexate in inflammatory bowel disease in 2014: A User's Guide |
| Q82681950 | [What's new in dermatological therapy?] |
Search more.